Jan 10, 2023 / 04:15PM GMT
David James Adlington - JPMorgan Chase & Co, Research Division - Head of Medical Technology & Services Equity Research
Great. Good morning, everybody. I'm David Adlington, Head of the European Medtech research team for JPMorgan. It's my pleasure to introduce Helen Giza, CEO of Fresenius Medical. There will be an opportunity for questions after the presentation. Thanks. Helen.
Helen Giza - Fresenius Medical Care AG - CEO & Chair of Management Board of Fresenius Med. Care Mgmt AG
Thank you, David, and good morning, everyone. It's great to be back in person after 2 years of remote participation. And it's also my first conference as CEO of Fresenius Medical Care. I joined the company 3 years ago and have worn a number of hats over those past 3 years, initially as CFO, then Chief Transformation Officer. And during that time, I feel like I've really got to know this business really well. And I think whole-heartedly I can say this patient-centric mission-driven company is a great company with great people, great assets and truly a great future. Obviously,
Fresenius Medical Care AG & Co KGaA at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot